Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
39.64
+0.88 (2.27%)
At close: Jul 16, 2024, 4:00 PM
39.60
-0.04 (-0.10%)
Pre-market: Jul 17, 2024, 4:00 AM EDT

Amphastar Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2011
Revenue
676.21644.4498.99437.77349.85322.36
Upgrade
Revenue Growth (YoY)
30.38%29.14%13.98%25.13%8.53%9.40%
Upgrade
Cost of Revenue
308.83293.27250.13238.03206.51190.43
Upgrade
Gross Profit
367.38351.12248.86199.74143.34131.92
Upgrade
Selling, General & Admin
84.8580.3966.5968.9265.1663.11
Upgrade
Research & Development
70.9773.7474.7760.9367.2368.85
Upgrade
Operating Expenses
155.82154.13141.36129.85132.39131.96
Upgrade
Operating Income
211.56196.99107.569.8910.95-0.04
Upgrade
Interest Expense / Income
35.3727.161.850.890.370.12
Upgrade
Other Expense / Income
-7.70.45-9.21-13.745.64-62.82
Upgrade
Pretax Income
183.9169.38114.8682.754.9462.66
Upgrade
Income Tax
29.2131.8323.4820.633.5413.72
Upgrade
Net Income
154.69137.5591.3962.121.448.94
Upgrade
Net Income Growth
66.04%50.51%47.12%4327.37%-97.13%-
Upgrade
Shares Outstanding (Basic)
484849484747
Upgrade
Shares Outstanding (Diluted)
535352504950
Upgrade
Shares Change
2.01%1.09%5.31%1.34%-1.57%7.57%
Upgrade
EPS (Basic)
3.202.851.881.300.031.04
Upgrade
EPS (Diluted)
2.902.601.741.250.030.98
Upgrade
EPS Growth
62.92%49.43%39.20%4066.67%-96.94%-
Upgrade
Free Cash Flow
160.93145.3465.5770.5423.410.21
Upgrade
Free Cash Flow Per Share
3.343.011.351.480.500.00
Upgrade
Gross Margin
54.33%54.49%49.87%45.63%40.97%40.92%
Upgrade
Operating Margin
31.29%30.57%21.54%15.96%3.13%-0.01%
Upgrade
Profit Margin
22.88%21.34%18.31%14.19%0.40%15.18%
Upgrade
Free Cash Flow Margin
23.80%22.55%13.14%16.11%6.69%0.06%
Upgrade
Effective Tax Rate
15.88%18.79%20.44%24.93%71.62%21.90%
Upgrade
EBITDA
248.86225.48144.03109.0929.4682.87
Upgrade
EBITDA Margin
36.80%34.99%28.86%24.92%8.42%25.71%
Upgrade
Depreciation & Amortization
29.5928.9527.3225.4624.1420.08
Upgrade
EBIT
219.27196.54116.7183.635.3262.78
Upgrade
EBIT Margin
32.43%30.50%23.39%19.10%1.52%19.48%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).